Dishaditi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-12-2024
- Paid Up Capital ₹ 1.00 M
as on 23-12-2024
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2019
About Dishaditi Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rajan Prashanth and Murthy Krishnappa serve as directors at the Company.
- CIN/LLPIN
U74999KA2018PTC110254
- Company No.
110254
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2018
- Date of AGM
31 Dec 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Dishaditi Pharma Private Limited offer?
Dishaditi Pharma Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cardiac Drugs, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Common Disease Medicines, Anaemia Medicine, Brain & Nervous System Drugs, Immunomodulator Drugs, Kidney Drugs, TB, Tumor & Cancer Drugs.
Who are the key members and board of directors at Dishaditi Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajan Prashanth  | Whole-Time Director | 19-Feb-2018 | Current |
| Murthy Krishnappa | Director | 01-Oct-2019 | Current |
Financial Performance of Dishaditi Pharma.
Dishaditi Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dishaditi Pharma?
Unlock access to Dishaditi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Prime Health 5D (India) Private LimitedActive 12 years 6 monthsMurthy Krishnappa is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dishaditi Pharma?
Unlock and access historical data on people associated with Dishaditi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dishaditi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dishaditi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
